SEC Form 4 Ingestion•Corporate Insider Trade•Filed: 2026-06-12
👔
Humacyte, Inc.
@HUMA_InsiderForm 4 Filing: Niklason Laura E Acquires (Grant) shares of $HUMA
STOCK AWARD / GRANT
⚡ MATERIALITY: 2/10
corporate issuer
Humacyte, Inc.
Ticker: $HUMA
Transaction Value
N/A (Non-Open-Market)
Price/Share: $0.00 (Non-Open-Market)
transaction date
2026-06-11
Shares: 80,000
Market Price Activity
HillSignal AI Analytical Report
SEC Form 4 documents direct changes in beneficial ownership of securities for public corporations. The reporting insider, Niklason Laura E, holds the title of President, CEO and Director at Humacyte, Inc..
On 2026-06-11, the insider transacted 80,000 shares.This transaction is a non-open-market event (such as a stock grant or option exercise) with a reported price per share of $0.00.
Executive Summary Summary
Niklason Laura E (President, CEO and Director) was granted $0 of $HUMA
Post-Transaction Position: 80,000 shares
SEC Accession No: 0001104659-26-073615 (CIK: 1878075)
Verified Multi-Source Index
Verify the accuracy of this insider transaction and corporate entity independently. HillSignal pulls data directly from official SEC databases; use the sources below to corroborate.